Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWCeftobiprole medocaril is a water-soluble prodrug form of the cephalosporin antibiotic ceftobiprole.1 In vivo, ceftobiprole medocaril (71 mg/kg) reduces the number of lung colony-forming units (CFUs) in mouse models of pneumonia induced by H. influenzae, E. cloacae, or K. pneumoniae. Formulations containing ceftobiprole medocaril have been used in the treatment of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia.
WARNING This product is not for human or veterinary use.
1. Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumonia. Diagn. Microbiol. Infect. Dis. 55(4), 333-336 (2006).